Colorado coalition a semifinalist for $100 million industry-building grant
By: Colorado BioScience Association Date: 03/04/2022
The grant, if won, would allow for construction of bioscience and cleantech projects throughout the Denver, Boulder and Fort Collins areas — and the development of programs to improve the pipelines of...
Learn MoreStatera Biopharma gets go-ahead for next phase of Crohn’s therapy trial
By: Colorado BioScience Association Date: 02/22/2022
Statera Biopharma Inc. (Nasdaq: STAB) has received approval from the Central Institutional Review Board to move forward with the third phase of its clinical trial for STAT-201, its candidate for the t...
Learn MoreRoy Smythe, M.D. and Scott Hutton Named to List of Top 25 Biotech CEOs of 2022
By: Colorado BioScience Association Date: 02/18/2022
CBSA Members' CEOs are named to Top 25 Biotech CEOs list: SomaLogic's Roy Smythe, M.D., and Biodesix's Scott Hutton. The Healthcare Technology Report is pleased to announce The Top 25 Biotech CEOs of...
Learn MoreEvoEndo Announces US FDA 510(k) Clearance for Single-Use Unsedated Transnasal Endoscopy (TNE) System
By: Colorado BioScience Association Date: 02/18/2022
EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), has announced the receipt of 510(k) clearance from the U.S. Food and Drug Administrati...
Learn MoreEvergreen Research Inc. is now ERI Group
By: Colorado BioScience Association Date: 02/02/2022
ERI Group, formerly Evergreen Research, a leader in end-to-end medical product design and development, quality assurance, regulatory affairs and contract manufacturing services, unveiled its new name...
Learn MoreBrickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences
By: Colorado BioScience Association Date: 02/02/2022
Brickell Biotech, Inc., a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmun...
Learn MoreLightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness
By: Colorado BioScience Association Date: 02/02/2022
LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today received a $2M contract from HJF, as funded by the Joint Program Executiv...
Learn MoreMining biotech opens Denver-area lab, plans quick expansion
By: Colorado BioScience Association Date: 02/01/2022
A fivefold jump in demand for for certain metals that are key to manufacturing the wind power, solar energy, batteries and other systems needed in the clean energy transition is forecast by 2050. The...
Learn MoreColorado startups crush venture funding record in 2021 with $6.5B raised
By: Colorado BioScience Association Date: 01/21/2022
In 2021, the state smashed previous venture funding records and closed the year with never-before-seen momentum. Find out more in the Denver Business Journal article.
Learn MoreSomaLogic announces exclusive partnership with Illumina to develop sequencing-based proteomic solutions
By: Colorado BioScience Association Date: 01/11/2022
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration with Illumina, a global next-generation sequencing technology leader. The m...
Learn More